Core Outcomes Set for Trials in People With Coronavirus Disease 2019
From Critical Care Medicine. The authors aimed to establish a core outcomes set for trials in people with suspected or confirmed coronavirus disease 2019.
International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019
From Critical Care Medicine. The author set out to generate a consensus-based, prioritized list of outcomes for coronavirus disease 2019 trials.
SCCM Pod-414 COVID-19 VIRUS Registry Aims to Identify Effective Treatment Strategies
Discovery, the Critical Care Research Network's Viral Infection and Respiratory Illness Universal Study creates a real-time COVID-19 registry of current ICU and hospital care patterns.
What is the recommended role of serial laboratory studies, including troponin, creatin kinase and D-dimer in the management of a hypercoagulable state?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.
SCCM Pod-413 COVID-19 Fact Versus Science Fiction
Explore the need for randomized COVID-19 clinical trials and the difficulties and potential consequences of misinformation (Ingraham N, et al. Crit Care Explor. 2020;2:e0108) with host Ashish K. Khanna, MD, FCCP, FCCM, and Nicholas E. Ingraham, MD.
Using Interfron When Treating COVID-19
This presentation is an overview of interferon use for COVID-19 patients. This is SCCM curated COVID-19 microlearning content.
Do you have an update on treatment options, such as open and ongoing clinical trials?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Question and Answer Webcast Series - Webcast 2 held on April 10, 2020.